Deciphera markets Qinlock, a drug for patients with advanced gastrointestinal stromal tumors, or GIST, a type of cancer that begins in the... Read this story
Deciphera markets Qinlock, a drug for patients with advanced gastrointestinal stromal tumors, or GIST, a type of cancer that begins in the... Read this story
More from STAT | biotechnology Deciphera Pharmaceuticals Ono Pharmaceutical Japan Pharmaceutical industry NASDAQ:DCPH